STOCK TITAN

American Shared Hospital Services 10-Q Filings

AMS NYSE

Every 10-Q that American Shared Hospital Services (AMS) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-Q covers the quarterly report filed between annual reports, so if you follow AMS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AMS filings page.

Rhea-AI Summary

American Shared Hospital Services reported higher revenues but continued losses and mounting balance-sheet pressure for the quarter ended June 30, 2026. Total revenue rose to $8,430,000 for the quarter and $15,514,000 for the first six months of 2026, up from $7,071,000 and $13,183,000 a year earlier, driven mainly by growth in the direct patient services segment in Rhode Island and Puebla and increased PBRT and Gamma Knife volumes internationally. Leasing revenue was essentially flat.

Despite top-line growth, the company posted a net loss attributable to shareholders of $514,000 in Q2 and $1,126,000 for the first half, with higher operating costs at direct patient facilities and a large $909,000 credit-loss allowance increase weighing on margins. Cash from operations improved to $4,385,000 in the first half, while cash and restricted cash totaled $6,761,000 at June 30, 2026.

Leverage and covenant breaches are a central concern. Long-term debt stood at $16,216,000, and the company was not in compliance with multiple covenants under its Fifth Third credit agreement and the DFC loan, leading to default notices and a standstill arrangement through June 30, 2027. Management concluded that these conditions raise substantial doubt about the company’s ability to continue as a going concern.

Rhea-AI Summary

American Shared Hospital Services reported first-quarter 2026 revenue of $7,084,000, up from $6,112,000 a year earlier, driven mainly by growth in direct patient services and higher proton beam volumes. The company still posted a net loss attributable to shareholders of $612,000, or $0.09 per share. Management disclosed covenant breaches and nonpayment of all amounts due at the April 2026 maturity of its $22,000,000 credit agreement, and warned that these issues raise substantial doubt about its ability to continue as a going concern.

Rhea-AI Summary

American Shared Hospital Services restated its September 30, 2025 balance sheet to reclassify $8,631,000 of debt as a current liability and disclosed covenant defaults that raise substantial doubt about its ability to continue as a going concern.

The company is in default under a $22,000,000 credit agreement with Fifth Third Bank and may be in default under a DFC loan, giving lenders the right to accelerate repayment even though they have not done so yet. At September 30, 2025, cash and cash equivalents were $5,095,000, current liabilities were $25,802,000, and all $18,184,000 of long-term debt was classified as current.

For the third quarter, revenue was $7,171,000 and net loss attributable to American Shared Hospital Services was $17,000, with nine‑month revenue of $20,354,000 and a net loss of $922,000. Direct patient services continued to grow year over year, while leasing revenue declined and higher interest and depreciation kept the business unprofitable.

Rhea-AI Summary

American Shared Hospital Services (AMS) reported Q3 2025 results showing modest top-line growth and a near breakeven bottom line. Revenue reached $7,171,000, up from $6,999,000 a year ago. Gross margin was $1,586,000. The company posted an operating loss of $344,000 and a net loss attributable to AMS of $17,000. Segment mix remained balanced, with leasing revenue of $3,137,000 and direct patient services of $4,034,000.

Year-to-date, operating cash flow improved to $3,802,000, while capital spending drove investing cash outflows of $9,618,000. Cash and restricted cash were $5,345,000 at September 30, 2025, and long‑term debt was $18,184,000. AMS had $2,000,000 outstanding on its $7,000,000 revolver at quarter‑end, which was repaid in October 2025. The company received a limited waiver under its credit agreement related to the funded debt to EBITDA covenant for June 30, 2025 and was in compliance as of September 30, 2025. Equipment and service commitments totaled $7,884,000 and $6,870,000, respectively. Shares outstanding were 6,543,000 as of November 11, 2025.

Rhea-AI Summary

American Shared Hospital Services reported modest top-line growth but swung to losses for the periods presented. Total revenue was $7.07 million for the three months and $13.18 million for the six months ended June 30, 2025, up slightly from $7.06 million and $12.27 million a year earlier. The growth was driven by higher direct patient services revenue (three months: $3.50M; six months: $6.62M) largely reflecting results from the Rhode Island acquisition and the Puebla facility, while leasing revenue fell (three months: $3.57M; six months: $6.56M) as two customer contracts expired and PBRT volumes declined.

The company reported a net loss attributable to American Shared Hospital Services of $0.28M for the quarter and $0.905M for the six months, versus net income in the prior-year periods. Cash and equivalents totaled $11.08M (cash, $11.331M including restricted cash), total assets were $63.49M, total liabilities $34.65M, and long-term debt was $19.09M. Material items include equipment purchase and service commitments (~$8.39M and $11.93M respectively) and a temporary covenant breach under the Fifth Third credit facility as of June 30, 2025 (compliance restored July 1, 2025).